Favivir Priced at Rs. 59 Per Tablet
Hyderabad: Hetero, one of India’s leading generic pharmaceutical companies, today announced the launch of generic Favipiravir in India under the brand name ‘Favivir’ to treat mild to moderate Covid-19 patients.
Favivir is priced at Rs. 59 per tablet and is marketed and distributed by Hetero Healthcare Limited. The product is available from today at all retail medical outlets and hospital pharmacies across the country and will be sold only on prescription, the company said in a statement.
Hetero has been granted the manufacturing and marketing approval for Favipiravir from the Drug Controller General of India (DCGI).
Favivir is the second drug developed by Hetero after Covifor (Remdesivir) used in the treatment of Covid-19. It is an oral antiviral medication that has demonstrated positive clinical outcomes.
Favivir improves treatment accessibility to a significant amount of Covid19 patient population, which usually sustains mild to moderate symptoms.
Comments are closed.